Halley Gilbert

Ms. Gilbert joined the Arcutis Board in May 2020. She brings significant experience in legal, corporate and business development, compliance and government affairs. Ms. Gilbert was most recently with Ironwood Pharmaceuticals, where she had been Senior Vice President for Corporate Development and Chief Administrative Officer, and where she oversaw corporate and business development, legal, compliance and government affairs. Previously, she had been Ironwood’s Senior Vice President, Chief Legal Officer and Corporate Secretary. Prior to joining Ironwood, Ms. Gilbert was Vice President, Deputy General Counsel at Cubist Pharmaceuticals, Inc. and previously served as a corporate counsel at Genzyme Corp., prior to its acquisition by Sanofi. She began her career at Skadden, Arps, Slate, Meagher & Flom LLP, where she specialized in mergers and acquisitions and securities law.

She currently serves on the board of directors for Allergy Amulet, a private, venture-backed company developing a food allergen detection device, and for CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutic. Ms. Gilbert previously served on the board of directors for Dermira, Inc. (acquired by Eli Lilly and Company), a commercial-stage company focused on medical dermatology drugs, and Achaogen, Inc., a commercial-stage biopharmaceutical company that developed novel antibacterial therapies.

Ms. Gilbert holds a B.A. in Political Science from Tufts University and J.D. from Northwestern University School of Law.